Purification_NN
and_CC
characterization_NN
of_IN
the_DT
human_JJ
SR_NN
31747A-binding_JJ
protein_NN
._.

A_DT
nuclear_JJ
membrane_NN
protein_NN
related_JJ
to_TO
yeast_NN
sterol_NN
isomerase_NN
._.

SR_NN
31747A_NN
,_,
defined_VBN
as_IN
a_DT
sigma_NN
ligand_NN
,_,
is_VBZ
a_DT
novel_JJ
immunosuppressive_JJ
agent_NN
that_WDT
blocks_VBZ
proliferation_NN
of_IN
human_JJ
and_CC
mouse_NN
lymphocytes_NNS
._.

Using_VBG
a_DT
radiolabeled_VBN
chemical_JJ
probe_NN
,_,
we_PRP
here_RB
purified_VBD
a_DT
target_NN
of_IN
SR_NN
31747A_NN
and_CC
called_VBD
it_PRP
SR_JJ
31747A-binding_JJ
protein_NN
-LRB-_-LRB-
SR-BP_NN
-RRB-_-RRB-
._.

Purified_VBN
SR-BP_NN
retained_VBD
its_PRP$
binding_NN
properties_NNS
and_CC
migrated_VBD
on_IN
SDS-polyacrylamide_NN
gel_NN
as_IN
a_DT
Mr_NN
28,000_CD
protein_NN
._.

Cloning_NN
of_IN
the_DT
cDNA_NN
encoding_VBG
human_JJ
SR-BP_NN
shows_VBZ
an_DT
open_JJ
reading_NN
frame_NN
for_IN
a_DT
223-amino_NN
acid_NN
protein_NN
,_,
which_WDT
is_VBZ
homologous_JJ
to_TO
the_DT
recently_RB
cloned_VBN
sigma_NN
1_CD
receptor_NN
._.

Interestingly_RB
,_,
the_DT
deduced_VBN
amino_NN
acid_NN
sequence_NN
was_VBD
found_VBN
to_TO
be_VB
related_JJ
to_TO
fungal_JJ
C8-C7_NN
sterol_NN
isomerase_NN
,_,
encoded_VBN
by_IN
the_DT
ERG2_NN
gene_NN
._.

The_DT
ERG2_NN
gene_NN
product_NN
has_VBZ
been_VBN
identified_VBN
recently_RB
as_IN
the_DT
molecular_JJ
target_NN
of_IN
SR_NN
31747A_NN
that_WDT
mediates_VBZ
antiproliferative_JJ
effects_NNS
of_IN
the_DT
drug_NN
in_IN
yeast_NN
._.

Northern_NN
blot_NN
analysis_NN
of_IN
SR-BP_NN
gene_NN
expression_NN
revealed_VBD
a_DT
single_JJ
transcript_NN
of_IN
2_CD
kilobases_NNS
which_WDT
was_VBD
widely_RB
expressed_VBN
among_IN
organs_NNS
,_,
with_IN
the_DT
highest_JJS
abundance_NN
in_IN
liver_NN
and_CC
the_DT
lowest_JJS
abundance_NN
in_IN
brain_NN
._.

Subcellular_JJ
localization_NN
analysis_NN
in_IN
various_JJ
cells_NNS
,_,
using_VBG
a_DT
specific_JJ
monoclonal_JJ
antibody_NN
raised_VBN
against_IN
SR-BP_NN
,_,
demonstrated_VBD
that_IN
this_DT
protein_NN
was_VBD
associated_VBN
with_IN
the_DT
nuclear_JJ
envelope_NN
._.

When_WRB
studying_VBG
the_DT
binding_NN
of_IN
SR_NN
31747A_NN
on_IN
membranes_NNS
from_IN
yeast_NN
expressing_VBG
SR-BP_NN
,_,
we_PRP
found_VBD
a_DT
pharmacological_JJ
profile_NN
of_IN
sigma_NN
1_CD
receptors_NNS
;_:
binding_NN
was_VBD
displaced_VBN
by_IN
-LRB-_-LRB-
+_LS
-RRB-_-RRB-
-_CC
pentazocine_NN
,_,
haloperidol_NN
,_,
and_CC
-LRB-_-LRB-
+_LS
-RRB-_-RRB-
-_CC
SKF_NN
10,047_CD
,_,
with_IN
-LRB-_-LRB-
+_NN
-RRB-_-RRB-
-_:
SKF_NN
10,047_VBN
being_VBG
a_DT
more_RBR
potent_JJ
competitor_NN
than_IN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
-_:
SKF_NN
10,047_CD
._.

Scatchard_NN
plot_NN
analysis_NN
revealed_VBD
Kd_NN
values_NNS
of_IN
7.1_CD
nM_NN
and_CC
0.15_CD
nM_NN
for_IN
-LRB-_-LRB-
+_LS
-RRB-_-RRB-
-_CC
pentazocine_NN
and_CC
SR_NN
31747A_NN
,_,
respectively_RB
,_,
indicating_VBG
an_DT
affinity_NN
of_IN
SR-BP_NN
50-fold_RB
higher_JJR
for_IN
SR_NN
31747A_NN
than_IN
for_IN
pentazocine_NN
._.

Additionally_RB
,_,
we_PRP
showed_VBD
that_IN
pentazocine_NN
,_,
a_DT
competitive_JJ
inhibitor_NN
of_IN
SR_NN
31747A_NN
binding_NN
,_,
also_RB
prevents_VBZ
the_DT
immunosuppressive_JJ
effect_NN
of_IN
SR_NN
31747A_NN
._.

Taken_VBN
together_RB
,_,
these_DT
findings_NNS
strongly_RB
suggest_VBP
that_IN
SR-BP_NN
represents_VBZ
the_DT
molecular_JJ
target_NN
for_IN
SR_NN
31747A_NN
in_IN
mammalian_JJ
tissues_NNS
,_,
which_WDT
could_MD
be_VB
critical_JJ
for_IN
T_NN
cell_NN
proliferation_NN
._.

